GLUT-1 immunoexpression in oral epithelial dysplasia, oral squamous cell carcinoma, and verrucous carcinoma

被引:31
作者
Angadi, Vidya C. [1 ]
Angadi, Punnya V. [1 ]
机构
[1] KLEVK Inst Dent Sci & Hosp, Dept Oral Pathol & Microbiol, Belgaum 590010, Karnataka, India
关键词
GLUT-1; oral epithelial dysplasia; oral squamous cell carcinoma; verrucous carcinoma; histologic differentiation; glucose transport; POOR-PROGNOSIS; EXPRESSION; GLUCOSE-TRANSPORTER-1; HYPOXIA; OVEREXPRESSION; MARKERS; TUMORS; HEAD;
D O I
10.2334/josnusd.57.115
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Glucose transporters, such as GLUT-1, mediate the important mechanisms involved in cellular glucose influx, allowing cells to proliferate and survive. The significance of GLUT-1 expression in oral epithelial dysplasia (OED) and oral squamous cell carcinoma (OSCC) has been less explored, and no study has investigated it in relation to verrucous carcinoma (VC). We evaluated 30 cases each of OED, OSCC, and VC, graded further on the basis of their differentiation, immunohistochemically for GLUT-1 expression, along with 10 specimens of normal oral mucosa (NOM) as controls. In OSCC, GLUT-1 expression increased with the degree of dysplasia and increasing grade (P < 0.001). The expression in VC was predominantly membranous and intense, resembling well differentiated OSCC. This increase of GLUT-1 expression in OSCC along with the degree of dysplasia and the histologic grade reflects the expanding glycolytic response to hypoxia. This is the first study to have revealed prominent GLUT-1 expression in VC, highlighting its inherent metabolic capacity.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 24 条
[1]  
Airley R, 2001, CLIN CANCER RES, V7, P928
[2]   Expression of hexokinase II and Glut-1 in untreated human breast cancer [J].
Brown, RS ;
Goodman, TM ;
Zasadny, KR ;
Greenson, JK ;
Wahl, RL .
NUCLEAR MEDICINE AND BIOLOGY, 2002, 29 (04) :443-453
[3]   GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker [J].
Carvalho, Katia C. ;
Cunha, Isabela W. ;
Rocha, Rafael M. ;
Ayala, Fernanda R. ;
Cajaiba, Mariana M. ;
Begnami, Maria D. ;
Vilela, Rafael S. ;
Paiva, Geise R. ;
Andrade, Rodrigo G. ;
Soares, Fernando A. .
CLINICS, 2011, 66 (06) :965-972
[4]   Comparison of Myofibroblasts Expression in Oral Squamous Cell Carcinoma, Verrucous Carcinoma, High Risk Epithelial Dysplasia, Low Risk Epithelial Dysplasia and Normal Oral Mucosa [J].
Chaudhary M. ;
Gadbail A.R. ;
Vidhale G. ;
Mankar M.P. ;
Gondivkar S.M. ;
Gawande M. ;
Patil S. .
Head and Neck Pathology, 2012, 6 (3) :305-313
[5]   Glucose transporter-1 (GLUT-1):: a potential marker of prognosis in rectal carcinoma? [J].
Cooper, R ;
Sarioglu, S ;
Sökmen, S ;
Füzün, M ;
Küpelioglu, A ;
Valentine, H ;
Görken, IB ;
Airley, R ;
West, C .
BRITISH JOURNAL OF CANCER, 2003, 89 (05) :870-876
[6]   Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients [J].
Eckert, Alexander W. ;
Lautner, Matthias H. W. ;
Schuetze, Andreas ;
Taubert, Helge ;
Schubert, Johannes ;
Bilkenroth, Udo .
HISTOPATHOLOGY, 2011, 58 (07) :1136-1147
[7]  
Gale N., 2005, Pathology and genetics of head and neck tumours, P177
[8]  
Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO
[9]  
2-E
[10]   Thalidomide: features and potential significance in oral precancerous conditions and oral cancer [J].
Jin, Xin ;
Lu, Shujing ;
Xing, Xue ;
Wang, Lili ;
Mu, Dongliang ;
He, Mingjing ;
Huang, Haiyun ;
Zeng, Xin ;
Chen, Qianming .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013, 42 (05) :355-362